Figure 2
Figure 2. Increased accumulation of myeloid cells in the spleen of D6−/− mice after CFA injection. FACS analysis of BM, spleen, and blood harvested from WT and D6−/− mice injected subcutaneously with 200 μL of CFA in the right flank. BM CD11b+/Ly6Chigh monocytes (A) and CD11b+/Ly6G+ granulocytes (D), expressed as fold increase of the percentage of CD45+ leukocytes, recovered at indicated time points. Fold increase of the absolute number of monocytes (B-C) and granulocytes (E-F) in blood and spleen of D6−/− (■) versus WT (□) mice. (G) Fold increase of the absolute number of CD11b+/Ly6Chigh monocytes in blood of D6−/− (■) versus WT (□) mice after 4 weeks of splenectomy or sham operated before and after 48 hours CFA treatment. In all panels, data are representative of 2 independent experiments (n = 4 mice/time point). Data are mean ± SD. *P < .05 comparing D6−/− and WT animals.

Increased accumulation of myeloid cells in the spleen of D6−/− mice after CFA injection. FACS analysis of BM, spleen, and blood harvested from WT and D6−/− mice injected subcutaneously with 200 μL of CFA in the right flank. BM CD11b+/Ly6Chigh monocytes (A) and CD11b+/Ly6G+ granulocytes (D), expressed as fold increase of the percentage of CD45+ leukocytes, recovered at indicated time points. Fold increase of the absolute number of monocytes (B-C) and granulocytes (E-F) in blood and spleen of D6−/− (■) versus WT (□) mice. (G) Fold increase of the absolute number of CD11b+/Ly6Chigh monocytes in blood of D6−/− (■) versus WT (□) mice after 4 weeks of splenectomy or sham operated before and after 48 hours CFA treatment. In all panels, data are representative of 2 independent experiments (n = 4 mice/time point). Data are mean ± SD. *P < .05 comparing D6−/− and WT animals.

Close Modal

or Create an Account

Close Modal
Close Modal